Icagen, Inc. · Durham, NC United States
Key Icagen, Inc. Financials
| Company Type | Private - Single Location |
|---|---|
| Fiscal Year-End | December |
| 2010 Sales (mil.) | $10.5 |
| 2010 Employees | 38 |
Icagen, Inc. Income Statement
| Dec 10 | Dec 09 | Dec 08 | |
| Revenue | 10.5 | 9.6 | 12.3 |
| Cost of Goods Sold | 0.0 | 0.0 | 0.0 |
| Gross Profit | 10.5 | 9.6 | 12.3 |
| Gross Profit Margin | 100% | 100% | 100% |
| SG&A Expense | 4.3 | 4.3 | 5.7 |
| Depreciation & Amortization | 0.8 | 0.8 | 0.8 |
| Operating Income | (7.0) | (12.7) | (15.6) |
| Operating Margin | -66.8% | -132% | -126.9% |
| Nonoperating Income | 0.7 | 0.0 | 0.0 |
| Nonoperating Expenses | (0.1) | (0.1) | 0.8 |
| Income Before Taxes | (6.4) | (12.9) | (14.8) |
| Income Taxes | (0.0) | (0.1) | |
| Net Income After Taxes | (6.4) | (12.8) | (14.8) |
| Continuing Operations | (6.4) | (12.8) | (14.8) |
| Discontinued Operations | -- | -- | -- |
| Total Operations | (6.4) | (12.8) | (14.8) |
| Total Net Income | (6.4) | (12.8) | (14.8) |
| Net Profit Margin | -60.4% | -132.6% | -120.5% |
| Diluted EPS from Total Net Income | (1.06) | (2.16) | (2.56) |
| Dividends per Share | -- | -- | -- |
All amounts in millions of US Dollars except per share amounts.
Icagen, Inc. Balance Sheet
| Assets | Dec 10 | Dec 09 | Dec 08 |
| Current Assets | |||
| Cash | 12.0 | 18.1 | 34.2 |
| Net Receivables | 0.6 | 0.0 | 0.0 |
| Inventories | -- | -- | -- |
| Other Current Assets | 0.2 | 0.6 | 0.6 |
| Total Current Assets | 12.9 | 18.8 | 34.8 |
| Net Fixed Assets | 1.3 | 1.8 | 2.6 |
| Other Noncurrent Assets | 0.3 | 0.4 | 0.5 |
| Total Assets | 14.5 | 21.1 | 37.9 |
| Liabilities | Dec 10 | Dec 09 | Dec 08 |
| Current Liabilities | |||
| Accounts Payable | 0.7 | 1.1 | 1.4 |
| Short-Term Debt | 0.3 | 0.5 | 0.7 |
| Other Current Liabilities | 1.4 | 2.0 | 6.3 |
| Total Current Liabilities | 2.5 | 3.6 | 8.4 |
| Long-Term Debt | 0.1 | 0.5 | 1.0 |
| Other Noncurrent Liabilities | 0.3 | 0.3 | 0.4 |
| Total Liabilities | 2.9 | 4.4 | 9.8 |
| Shareholder's Equity | |||
| Preferred Stock Equity | -- | -- | -- |
| Common Stock Equity | 11.7 | 16.7 | 28.1 |
| Total Equity | 11.7 | 16.7 | 28.1 |
| Shares Outstanding (thou.) | 6,326.4 | 5,921.9 | 5,863.1 |
All amounts in millions of US Dollars except per share amounts.
Icagen, Inc. Cash Flow Statement
| Dec 10 | Dec 09 | Dec 08 | |
| Net Operating Cash Flow | (6) | (15) | (18) |
| Net Investing Cash Flow | (0.2) | (0.1) | (1.6) |
| Net Financing Cash Flow | (0.2) | (0.6) | 10.4 |
| Net Change in Cash | (6.1) | (16.1) | (9.3) |
| Depreciation & Amortization | 0.8 | 0.8 | 0.8 |
| Capital Expenditures | (0.2) | (0.1) | (1.6) |
| Cash Dividends Paid |
All amounts in millions of US Dollars except per share amounts.